Your session is about to expire
← Back to Search
Metformin for Prostate Cancer Patients with Glucose Intolerance or Overweight
Study Summary
This trial will test if it is feasible to enroll prostate cancer patients who have glucose intolerance or are overweight to a study where they receive metformin to see if it has any benefits.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a man aged 18 or older.You have high blood sugar or are overweight, and can take metformin.I am not on medications that badly interact with metformin.I have not taken any medication that increases the risk of lactic acidosis.I am taking medication for my diabetes.
- Group 1: Metformin and Lifestyle Modification Arm
- Group 2: Lifestyle Modification Only Arm
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researchers currently in search of participants for this research project?
"Analysis of the clinicaltrials.gov webpage suggests that this trial is not currently accepting new patients. This study was initially posted on January 25th 2023, and last updated in August 22nd 2022. Despite being inactive, 1450 other studies are still searching for willing participants."
How widely dispersed is this medical experiment being conducted?
"Currently, this trial is recruiting at four sites -- Aurora, Denver and Colorado Springs to name a few. It may be beneficial for prospective participants to select the local site that requires minimal travel expenditure."
Share this study with friends
Copy Link
Messenger